Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
283 Leser
Artikel bewerten:
(1)

Doceree Sets the Global Standard for Healthcare Marketing, Building the World's Largest Network of Specialist Medical Publishers

Two AI-powered solutions redefine how 2,000+ specialist medical publishers and healthcare advertisers connect-securely, compliantly, and at scale.

SHORT HILLS, N.J., Jan. 16, 2026 /PRNewswire/ -- Doceree, the only AI-powered Operating System for healthcare marketing, today announced a defining industry milestone: the creation of the world's largest network of specialist medical publishers, connecting more than 2,000 premium medical, clinical, and professional publishing platforms with endemic healthcare advertisers through its healthcare-native AI platform suite.

Doceree Sets the Global Standard for Healthcare Marketing, Building the World's Largest Network of Specialist Medical Publishers

This global network includes some of the most trusted medical publishing brands in the world and represents a fundamental shift in how healthcare media is monetized, measured, and scaled-away from generic ad technology and towards AI-first infrastructure built exclusively for regulated clinical environments.

A Structural Shift in Healthcare Media

Doceree's publisher network milestone is powered by the launch of two breakthrough AI-driven solutions introduced in 2025:

  • AdManager - the industry's first unified ad management and monetization platform built exclusively for healthcare publishers
  • Premium Programmatic - a programmatic advertising solution powered by patented MeSH Taxonomy, designed to engage physicians at their most critical reading and learning moments

Together, these solutions redefine how publishers unlock demand and how pharmaceutical and life sciences brands reach healthcare professionals-with precision, compliance, and contextual relevance.

As healthcare publishers increasingly outgrew broad-market ad platforms (that were never intended for regulated clinical ecosystems), Doceree's purpose-built approach saw rapid adoption across the world's most trusted medical publishers.

"Partnering with Doceree has been transformative for our global strategy," said Andy May, Global Head of Promotions - Clinical, Springer Nature. "We've strengthened our footprint and seen a clear uplift in yield from endemic advertisers-without compromising trust or experience."

Why Pharma Brands Are Shifting Programmatic Spend to Doceree

What differentiates Doceree's network is not scale alone-it is the healthcare-specific intelligence embedded into every placement. Doceree delivers three advantages traditional programmatic platforms cannot match:

More Reach - Verified, Not Aggregated

  • 2,000+ directly integrated specialist medical platforms
  • 6M+ verified healthcare professionals across 45+ specialties
  • Direct publisher relationships-no resold or blind inventory

More Context - Precision Built for Medicine

  • Patented MeSH taxonomy of 7M+ clinical keywords
  • Real-time contextual targeting aligned with medical content
  • Deterministic NPI-based identity matching, enhanced with specialty and device-level intelligence

More Formats - Designed for How Physicians Learn

  • Sponsored scientific content, clinical case studies, and CME partnerships
  • Programmatically delivered branded articles within trusted environments
  • Integration with RepTwin, Doceree's AI-powered virtual representative available to physicians 24x7

The result is healthcare marketing that feels useful, credible, and clinically relevant, transforming advertising into meaningful medical dialogue.

"Healthcare marketing has outgrown generic programmatic models," said Harshit Jain, MD, Founder & Global CEO, Doceree. "What we've built with this publisher network is not just scale, but infrastructure-designed specifically for regulated, clinical environments. By connecting trusted medical publishers directly with endemic healthcare demand, we're setting a new global standard for how meaningful, compliant, and accountable HCP engagement should work."

A Purpose-Built Playground for Healthcare Publishers

For publishers, the shift to healthcare-native technology unlocked capabilities that generic ad platforms could never deliver-especially the ability to activate highly targeted, physician-only campaigns without compromising editorial integrity or user experience.

"AdManager allowed us to activate precision physician campaigns while protecting the reader experience," said Sarah Mayes, Director of Advertising, Taylor & Francis. "Every impression carried intent and value."

Unlike broad-market ad technology that treats healthcare as an edge case, AdManager and Premium Programmatic were engineered from the ground up for healthcare publishing realities.

"A dedicated healthcare ad manager was long overdue-and Doceree delivered," said Nicola Harris, Agency Account Director, Cogora.

A Clear Industry Signal

For publishers, Doceree delivers access to the deepest pool of endemic healthcare demand, higher CPMs, automated compliance monitoring, intelligent inventory management, and streamlined operations-all through a single healthcare-native platform.

"Healthcare publishers have outgrown generic ad platforms," said Vijay Adapala, EVP - Global Supply Partnerships, Doceree. "The growth of our publisher network confirms a clear industry shift toward solutions that prioritize relevance, compliance, and sustainable revenue."

With continued investment in AI, infrastructure, and global partnerships, Doceree plans multiple enhancements to AdManager and Premium Programmatic in 2026-further cementing its leadership in healthcare programmatic marketing.

Learn more:
AdManager - http://docereeadmanager.com
Premium Programmatic - https://doceree.com/premium-programmatic/

About Doceree

Doceree is the only AI-powered operating system for healthcare marketing. We believe the role of AI is to bring richer context to every HCP interaction. Our patented AI understands multiple layers of clinical, behavioral, and contextual signals to enhance every HCP interaction in a privacy-compliant manner, delivering measurably better outcomes every time. In just five years, we have emerged as leaders in AI-powered, hyper-personalized healthcare messaging-redefining HCP engagement with more powerful context and more powerful outcomes.

To learn more, visit www.doceree.ai

Photo: https://mma.prnewswire.com/media/2863437/DOCEREE_Global_Standard.jpg
Logo: https://mma.prnewswire.com/media/1758952/5721641/Doceree_Logo.jpg

Doceree Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/doceree-sets-the-global-standard-for-healthcare-marketing-building-the-worlds-largest-network-of-specialist-medical-publishers-302663329.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.